Udemy Inc header image

Udemy Inc

UDMY

Equity

ISIN US9026851066 / Valor 114176816

NASDAQ (2024-11-21)
USD 7.55%

Udemy Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Udemy Inc. is a global online learning platform offering a wide range of courses taught by expert instructors, catering to both professional development and personal interests.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (13.06.2024):

Revenue Growth

Udemy Inc reported a significant increase in revenue for the fourth quarter of 2023, with total revenue rising 15% year-over-year to $189.5 million. This growth exceeded the high end of Udemy’s guidance for the quarter by approximately $3 million, despite a negative impact of 1 percentage point from changes in foreign exchange rates year-over-year.

Enterprise Segment Expansion

The Enterprise segment, or Udemy Business, saw a notable revenue increase of 27% year-over-year to $114.7 million in the fourth quarter of 2023. This includes a negative impact of 2 percentage points from changes in foreign exchange rates. Udemy Business's Annual Recurring Revenue (ARR) also grew by 25% year-over-year to $466.0 million.

Consumer Segment Stability

Udemy Inc's Consumer segment revenue remained stable year-over-year at $74.9 million in the fourth quarter of 2023, including a negligible impact of less than one percentage point from changes in foreign exchange rates. This stability highlights the consistent demand for Udemy’s consumer-oriented educational content.

Net Loss Improvement

Udemy Inc reported a net loss of $20.2 million in the fourth quarter of 2023, which is a significant improvement from a net loss of $52.2 million in the same quarter the previous year. This 61% reduction in net loss reflects Udemy's enhanced operational efficiency and cost management strategies.

Share Repurchase Program

Reflecting confidence in its financial health and future prospects, Udemy Inc's Board of Directors approved the company's first share repurchase program. Under this program, Udemy is authorized to repurchase up to $100 million of its common stock, which may be conducted through open market or privately negotiated transactions in accordance with SEC regulations.

Summarized from source with an LLMView Source

Key figures

-45.6%1Y
-75.6%3Y
%5Y

Performance

56.8%1Y
59.6%3Y
59.6%5Y

Volatility

Market cap

2214 M

Market cap (USD)

Daily traded volume (Shares)

300,595

Daily traded volume (Shares)

1 day high/low

7.56 / 7.39

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Concentra Group Holdings Parent Inc
Concentra Group Holdings Parent Inc Concentra Group Holdings Parent Inc Valor: 136105334
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.91%USD 21.80
Bausch Health Companies Inc
Bausch Health Companies Inc Bausch Health Companies Inc Valor: 42260834
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.12%USD 8.18
Formycon AG
Formycon AG Formycon AG Valor: 12194189
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.17%EUR 46.50
McKesson Corp
McKesson Corp McKesson Corp Valor: 991041
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.15%USD 628.27
Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals PLC Jazz Pharmaceuticals PLC Valor: 14769757
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.91%USD 125.10
Ultragenyx Pharmaceutical Inc
Ultragenyx Pharmaceutical Inc Ultragenyx Pharmaceutical Inc Valor: 22860122
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.82%USD 46.02
LifeStance Health Group Inc
LifeStance Health Group Inc LifeStance Health Group Inc Valor: 111701745
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.25%USD 7.31
KK Kose
KK Kose KK Kose Valor: 1017515
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.83%JPY 6,776.00
Nxera Pharma KK
Nxera Pharma KK Nxera Pharma KK Valor: 1892568
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.52%JPY 1,137.00
Nippon Shinyaku KK
Nippon Shinyaku KK Nippon Shinyaku KK Valor: 763041
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.38%JPY 4,154.00